Aslak Rautio

Publications

Author

Title

Year sorteringsordning

Fulltext

Rautio, Aslak
Boman, Kurt
Gerstein, Hertzel C; et al.

The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial
Diabetes & Vascular Disease Research, 14(4): 345-352

2017

-

Rautio, Aslak

Diabetes Mellitus and Cardiovascular Risk: epidemiology, etiology and intervention

2016

Download

Rautio, Aslak
Boman, Kurt
Eriksson, Jan W; et al.

Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up
Diabetes & Vascular Disease Research, 13(3): 183-191

2016

-

Rautio, Aslak
Eliasson, Mats
Stegmayr, Birgitta

Favorable Trends in the Incidence and Outcome in Stroke in Nondiabetic and Diabetic Subjects Findings From the Northern Sweden MONICA Stroke Registry in 1985 to 2003
Stroke, 39(12): 3137-3144

2008

-

Lundblad, Dan
Dinesen, B
Rautio, Aslak; et al.

Low level of tissue plasminogen activator activity innon-diabetic patients with a first myocardial infarction
Journal of Internal Medicine, 258(1): 13-20

2005

-

Rautio, Aslak
Lundberg, Vivan
Messner, Torbjörn; et al.

Favourable trends in the incidence and outcome ofmyocardial infarction in nondiabetic, but not in diabetic, subjects: findings from the MONICA myocardial infarctionregistry in northern Sweden in 1989–2000
Journal of Internal Medicine, 258(4): 369-377

2005

-